I'm back from Berlin, Germany, where I attended the 34th annual ECTRIMS Congress, and the single biggest challenge that I faced during the 3-day conference was trying to decide which sessions I wanted to attend. With 80 live presentations, more than 1,000 poster presentations, and any number of meetings and even casual conversations that seem to pop up everywhere, it's challenging trying to take it all in. Although ECTRIMS has ended, there's still a bit more to report from the conference, so please consider this podcast episode as the ECTRIMS wrap-up.
We're talking about the effectiveness of a cannabidiol spray on MS spasticity. We'll tell you how environmental factors can impact MS, and we'll explain the two different environments you should be paying attention to. And you'll hear about the study that identified how neurofilament light chain levels can be used in clinical practice to identify which people living with relapsing remitting MS might be at greater risk of increased disease activity and progression.
And we'll wrap up our ECTRIMS 2018 episode by re-visiting my conversation with Bruce Bebo, Executive Vice-President of Research at the National MS Society. Bruce will share his perspective on some of the presentations that caught his attention during the conference, and we'll talk about the $12 million dollar research investment that the National MS Society had just announced.
The Efficacy of Cannabidiol Spray on MS Spasticity 1:50
The Impact of Environmental Factors on MS 3:35
Neurofilament light chain may identify people with RRMS who are at greater risk of disease progression 5:36
Interview with Bruce Bebo, Executive Vice-President of Research at the National MS Society 9:27
If your podcast app doesn't show these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS Episode 60
Hosted By: Jon Strum
Guest: Bruce Bebo, Ph.D.
Tags: MS, MultipleSclerosis, ECTRIMS2018, MSInsideOut, RealTalkMS